http://rdf.ncbi.nlm.nih.gov/pubchem/reference/34938552

Outgoing Links

Predicate Object
contentType Journal Article
issn 2666-3546
pageRange 100561-
publicationName Brain, Behavior, & Immunity - Health
startingPage 100561
hasFundingAgency http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_06aba5a94448c92faf09747c7e7c67bd
isSupportedBy http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_b0b628b6ad8c52ae251a6d71a489def0
http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_40a65d3513d01e85d56c8d6cb521bf09
bibliographicCitation Lombardo G, Nettis MA, Hastings C, Zajkowska Z, Mariani N, Nikkheslat N, Worrell C, Enache D, McLaughlin A, Kose M, Bogdanova A, Sforzini L, Cleare AJ, Young AH, Dazzan P, Mondelli V, Pariante CM. Sex differences in a double-blind randomized clinical trial with minocycline in treatment-resistant depressed patients: CRP and IL-6 as sex-specific predictors of treatment response. Brain, Behavior, & Immunity - Health. 2022 Dec;26():100561. doi: 10.1016/j.bbih.2022.100561.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0a7dd40fdf98021ba97e7090ec121501
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3b505224e9975c51ed7cea5a14055262
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8463c4f4266f8d8b36908d94528185b8
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_fb9f6e16e751030ffe3ae1c75c6e5215
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_eb0b6608ba5b29ca91fb2f10019380c8
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3c74308eb45ef690eb14b741b9df76dc
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e467d4ea389a2e67eee6a7a83bb73096
http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0003-2794-3917
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_792eaea622e8e422a711d675989768e1
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6c21a6519ad435a42e43943356c62fc4
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e98df43a98431f2a2055bdcd9a4b3818
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2ab3338c186fad16d746c045cc376d8d
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f44a669d343ea5029a3af5b5842d264f
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_788dfb06022aa90021487679fd2f17e0
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0e01ec097d09e6804751006abc9456e5
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ccb2f9eb00cb483cc2bddebe8c5e6c4c
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_776b7ba81bc205a1d55628190134fd06
date 202212
identifier https://pubmed.ncbi.nlm.nih.gov/36467125
https://pubmed.ncbi.nlm.nih.gov/PMC9712814
https://doi.org/10.1016/j.bbih.2022.100561
isPartOf https://portal.issn.org/resource/ISSN/2666-3546
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/49076
language English
source https://pubmed.ncbi.nlm.nih.gov/
https://www.crossref.org/
title Sex differences in a double-blind randomized clinical trial with minocycline in treatment-resistant depressed patients: CRP and IL-6 as sex-specific predictors of treatment response
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11392
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_a7939d043567ee90a9f1febb314e563d
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_db534dfb811794dcf8169959477d8ea5
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8173
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7427
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7428
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54675783
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_1f89d53127fac03812c245bc89053817

Showing number of triples: 1 to 44 of 44.